- Home
- NTRB vs TTOO Comparison
NTRB vs TTOO Comparison
Compare NTRB & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- TTOO
- Stock Information
- Founded
- NTRB 2016
- TTOO 2006
- Country
- NTRB United States
- TTOO United States
- Employees
- NTRB N/A
- TTOO N/A
- Industry
- NTRB Industrial Specialties
- TTOO Medical/Dental Instruments
- Sector
- NTRB Health Care
- TTOO Health Care
- Exchange
- NTRB Nasdaq
- TTOO Nasdaq
- Market Cap
- NTRB 77.9M
- TTOO 36.4M
- IPO Year
- NTRB N/A
- TTOO 2014
- Fundamental
- Price
- NTRB $6.17
- TTOO $0.97
- Analyst Decision
- NTRB
- TTOO Hold
- Analyst Count
- NTRB 0
- TTOO 1
- Target Price
- NTRB N/A
- TTOO $5.00
- AVG Volume (30 Days)
- NTRB 28.2K
- TTOO 710.5K
- Earning Date
- NTRB 12-11-2024
- TTOO 11-13-2024
- Dividend Yield
- NTRB N/A
- TTOO N/A
- EPS Growth
- NTRB N/A
- TTOO N/A
- EPS
- NTRB N/A
- TTOO N/A
- Revenue
- NTRB $1,803,816.00
- TTOO $7,164,000.00
- Revenue This Year
- NTRB N/A
- TTOO $50.31
- Revenue Next Year
- NTRB N/A
- TTOO $117.92
- P/E Ratio
- NTRB N/A
- TTOO N/A
- Revenue Growth
- NTRB N/A
- TTOO N/A
- 52 Week Low
- NTRB $1.93
- TTOO $0.90
- 52 Week High
- NTRB $9.60
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- NTRB 50.57
- TTOO 18.34
- Support Level
- NTRB $5.24
- TTOO $0.90
- Resistance Level
- NTRB $6.40
- TTOO $1.86
- Average True Range (ATR)
- NTRB 0.71
- TTOO 0.15
- MACD
- NTRB -0.12
- TTOO -0.00
- Stochastic Oscillator
- NTRB 33.23
- TTOO 5.72
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.